Finzati - Logo
VCEL logo

Vericel Corporation

VCEL • Biotechnology
$40.19
▼ -0.28 (-0.69%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$2.05B
Growth
-5.4%
Cash Flow
4/5
Trend
Mostly stable
Evidence
Positive revenue growth · 12.9%Positive free cash flow · 0.49Consistent free cash flow · 4/5Manageable debt level · 0.28Healthy liquidity · 5.03
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$40.19
Change-0.69%
Shares Out50.92M
Market Cap$2.05B
Enterprise Value$1.98B
52W Range28.95 - 49.32
Beta1.07
P/E84.50
P/S6.68
P/B5.53
P/FCF41.23
EV/Sales6.45

Investment DNA

How strong this company looks for long-term investors

59
out of 100
Business Quality
Margins, moat, returns
47/100
Financial Strength
Debt, cash, stability
90/100
Growth Potential
Revenue and expansion
71/100
Price Attractiveness
Cheap or expensive today
34/100
Why this score▼
Positive revenue growth · 12.9%Positive free cash flow · 0.49Consistent free cash flow · 4/5Manageable debt level · 0.28Healthy liquidity · 5.03Expensive earnings multiple · 110.29

Analyst view

Analyst sentiment and price target

VCEL
Analyst sentiment
Based on 14 analyst votes · 2026-09-05
82/100
Bullish
Bullish
9
Hold
5
Bearish
0
Price Target
2026-07-31
Low
$46.00
Mean
$57.50
Median
$57.00
High
$70.00

Company Overview

IPO: 2/4/1997
Industry: Biotechnology
P/B i: 5.53
Debt / Equity i: 0.28
Operating Margin: 4.00%
Net Margin: 5.98%
ROE i: -
ROIC: -

Financial Health

Score18 / 20
Debt / Equity: 0.28
Current Ratio: 5.03
Quick Ratio: 4.68
Status: Strong

Insider Transactions

Recent executive and insider activity

Flynn Sean C.
Transaction: 06/26/2026
SELL
Change
-15,000
Price
$45.64
Filing
06/30/2026
Type
SELL
Flynn Sean C.
Transaction: 06/26/2026
BUY
Change
+15,000
Price
$16.25
Filing
06/30/2026
Type
BUY
Hopper Jonathan Mark
Transaction: 06/26/2026
BUY
Change
+5,000
Price
$29.82
Filing
06/30/2026
Type
BUY